Licensing & Transactions


Capturing opportunities to grow and expand

To achieve an effective licensing or transactional strategy, you need to understand the underlying IP fully. As scientists and lawyers, we know how to evaluate the IP behind a license or transaction accurately to secure and protect your interests.

World-class strategic assistance

Clark+Elbing has broad experience working with both parties in licensing and transactions. Because we understand both sides of the transaction, we know how to address the key issues involved in negotiation and agreements. We assist clients in licensing, financings including private placements and public offerings, and other IP related contracts.

We work with a wide range of start-ups, technology transfer offices, and multinational corporations at the forefront of life science, chemistry, and devices. As scientists and IP lawyers, we bring a unique skill set to our licensing and transaction practice that is a strategic advantage to growing a business in areas including:

  • Antibodies
  • Biomarkers
  • Biomaterials
  • Cardiovascular devices
  • Cell-based therapies
  • Ceramics
  • Chemical and biological reactors
  • Chemical processes
  • Coatings
  • Consumer products
  • Cosmetics
  • Dental devices
  • Devices for improving urogenital and gastrointestinal health
  • Diagnostic devices
  • Diagnostics
  • Dialysis components
  • Drug delivery devices
  • Drug delivery systems
  • Drug formulations
  • Drug-device combination products
  • Drug-eluting stents
  • EEG headsets
  • Electronics and semiconductor materials
  • Environmental monitoring
  • Food and beverage equipment
  • Food processing
  • Gene therapy
  • Genetically-modified animals
  • Genomics
  • Green/clean energy technology
  • Imaging
  • Immunotherapies
  • Industrial automation and materials processing
  • Industrial hygiene
  • Laboratory equipment
  • Manufacturing & control systems
  • Manufacturing & packaging
  • Medical device coatings
  • Metabolomics
  • Microbiology
  • Microbiome therapies
  • Microfluidic devices
  • Microfluidics
  • Multiplex assays
  • Nanotechnology
  • Next generation sequencing
  • NMR devices
  • Nucleic acids
  • Nutraceuticals
  • Orthopedic devices
  • Peptides
  • Pharmaceuticals
  • Plant and agricultural technology
  • Plastics and polymer science
  • Proteomics
  • Repurposed drugs
  • Sequencing equipment
  • Stem cell technology
  • Therapeutic methods
  • Ultrasound and thermoacoustic imaging